CPZ
Calamos Long/Short Equity & Dynamic Income TrustMarquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q4 2024 | Q2 2025 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Calamos Long/Short Equity & Dynamic Income Trust. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Dec 18, 2025 — the most recent Form 4 on file — not from today.
- Form 40001248580-25-000009Dec 18, 2025
- Form 40001248580-25-000008Dec 17, 2025
- Form 40001248580-25-000007Dec 16, 2025
- Form 40001679182-25-000001Jan 31, 2025
- Form 40001234356-25-000001Jan 10, 2025
- Form 40001717457-24-000003Sep 20, 2024
- Form 40001717457-24-000002May 2, 2024
- Form 40001343519-24-000002Feb 15, 2024
- Form 40001679182-23-000004Dec 21, 2023
- Form 40001679182-23-000003Dec 20, 2023
- Form 40001679182-23-000001Dec 20, 2023
- Form 40001248580-23-000004Dec 19, 2023
- Form 40001248580-23-000003Dec 19, 2023
- Form 40001536407-21-000007Jun 22, 2021
- Form 40001536407-21-000006May 25, 2021
Fundamentals
XBRL · Calamos Long/Short Equity & Dynamic Income TrustNot enough XBRL history to plot. Calamos Long/Short Equity & Dynamic Income Trusthasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Calamos Long/Short Equity & Dynamic Income Trust — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14AProxy statementMay 11, 2026
- DEF 14AProxy statementMay 12, 2025
- SC 13D/AFORM SC 13D/ADec 6, 2024
- 8-KFORM 8-KMay 14, 2024
- DEF 14AProxy statementMay 14, 2024
- SC 13DFORM SC 13DMar 18, 2024
- SC 13G/AMS AMENDMENTFeb 12, 2024
- DEF 14AProxy statementMay 8, 2023
- SC 13G/AMS AMENDMENTFeb 8, 2023
- DEF 14AProxy statementMay 11, 2022
- SC 13G/AFORM SC 13G/AFeb 14, 2022
- SC 13GMS INITIALFeb 11, 2022
- DEF 14AProxy statementMay 12, 2021
- SC 13G/AFORM SC 13G/AFeb 12, 2021
- 8-KMaterial eventJan 12, 2021
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q4 2024 | Q2 2025 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.